What were Tarsons Products Ltd's latest quarterly results?
Tarsons Products Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: -4.2%
- Revenue Growth YoY: +12.8%
- Operating Margin: 29.2%
Tarsons Products Ltd (Medical Equipment) — fundamental analysis, earnings data, and key metrics. PE: 44.2. ROE: 4.8%. This stock is not currently in the Nifty 500 momentum outperformers list.
Based on publicly available financial data. This is educational research, not investment advice.
Tarsons Products Ltd's latest quarterly results (Dec 2025) show
Tarsons Products Ltd's current PE ratio is 44.2x.
Tarsons Products Ltd's price-to-book ratio is 1.5x.
Tarsons Products Ltd's fundamental strength based on key financial ratios
Tarsons Products Ltd has a debt-to-equity ratio of N/A.
Tarsons Products Ltd's return ratios over recent years
Tarsons Products Ltd's operating cash flow is positive (FY2025).
Tarsons Products Ltd currently does not pay a significant dividend (yield 0.00%).
Tarsons Products Ltd's shareholding pattern (Dec 2025)
Tarsons Products Ltd's promoter holding has decreased recently.
Tarsons Products Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Based on quantitative research signals, here is why Tarsons Products Ltd may be worth studying
Tarsons Products Ltd investment thesis summary:
Tarsons Products Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.